//
Hideki Nakasone
Kimikazu Yakushijin
Shigeo Fuji
Takahiro Fukuda
Makoto Onizuka
Akihito Shinohara
Kazuteru Ohashi
Koichi Miyamura
Naoyuki Uchida
Minoko Takanashi
Tatsuo Ichinohe
Yoshiko Atsuta
Department of Pediatrics, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital,
Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan
Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan
Japanese Data Center for Hematopoietic Cell Transplantation,
Department of Medicine, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital, Tokyo, Japan
Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan
Blood Service Headquarters, Japanese Red Cross, Tokyo, Japan
Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan
Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan
Japan
N/A
Blood/haematological Diseases
Acute lymphoblastic leukemia
Alpha-thalassemia myelodysplasia syndrome
Chronic Myelogenous Leukemia
Anemia
Hematocrit
Soluble Complement 5b-9
fludarabine tablet
N/A
N/A
NA
N/A
N/A
Interim